Fatty Acids
"Fatty Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed)
| Descriptor ID |
D005227
|
| MeSH Number(s) |
D10.251
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fatty Acids".
Below are MeSH descriptors whose meaning is more specific than "Fatty Acids".
This graph shows the total number of publications written about "Fatty Acids" by people in this website by year, and whether "Fatty Acids" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1998 | 1 | 4 | 5 | | 1999 | 1 | 2 | 3 | | 2000 | 2 | 1 | 3 | | 2001 | 2 | 2 | 4 | | 2002 | 1 | 4 | 5 | | 2003 | 1 | 8 | 9 | | 2004 | 3 | 5 | 8 | | 2005 | 3 | 7 | 10 | | 2006 | 4 | 5 | 9 | | 2007 | 7 | 2 | 9 | | 2008 | 4 | 4 | 8 | | 2009 | 4 | 3 | 7 | | 2010 | 7 | 3 | 10 | | 2011 | 3 | 1 | 4 | | 2012 | 5 | 7 | 12 | | 2013 | 4 | 4 | 8 | | 2014 | 9 | 7 | 16 | | 2015 | 9 | 7 | 16 | | 2016 | 3 | 9 | 12 | | 2017 | 7 | 3 | 10 | | 2018 | 3 | 11 | 14 | | 2019 | 9 | 7 | 16 | | 2020 | 7 | 7 | 14 | | 2021 | 8 | 11 | 19 | | 2022 | 7 | 11 | 18 | | 2023 | 0 | 11 | 11 | | 2024 | 2 | 5 | 7 | | 2025 | 5 | 7 | 12 | | 2026 | 3 | 3 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Fatty Acids" by people in Profiles.
-
Tabasso C, Gavini CK, Zemski Berry K, Salem H, Aguettaz AKF, Lagarrigue S, Bergman BC, Mansuy-Aubert V, Amati F. Organelle-Specific Lipid Profiles Underlie Metabolic Health in a Nutrition-Dependent Manner. Diabetes. 2026 Oct 01; 75(10):1753-1766.
-
Ingold M, Gao Q, Mandel JR, McNellie JP, Keepers KG, Barb JG, Burke JM, Rieseberg LH, Hulke BS. The stability of fatty acid composition in sunflower oil is dependent on environment and affected by structural variation. Theor Appl Genet. 2026 Aug 20; 139(9).
-
Bonaca MP, Canonico ME, Li N, Sasiela WJ, Nissen SE, Lincoff AM, Nicholls SJ. Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial. Circulation. 2026 Sep 15; 154(11):966-975.
-
Richbourg H, Rangel Miller V, Khazaie Japalaghi O, AlSayed M, Baker PR, Daugherty S, Ekstein T, GrĂ¼nert SC, Kiel MJ, Khan A, Kobayashi H, Korngut L, Monteleone SA, Schwartz IVD, Miller N, Vockley J. Long-Chain Fatty Acid Oxidation Disorder Genes: A Comprehensive Genetic Database of LC-FAOD Variants, Genotypes, and Phenotypes. Hum Mutat. 2026; 2026:6864813.
-
Heerspink HJL, van Raalte DH, Bjornstad P, Bunck MC, Wu P, Tunali I, Milicevic Z, Koeneman L. Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease. Nephrol Dial Transplant. 2026 May 29; 41(6):1058-1068.
-
Selby M, Duchamp C, Burchat N, Sharma P, Wu G, Pantula LG, Desai A, Miyazaki M, Sampath H. Intestinal stearoyl-CoA desaturase-2 is highly expressed and nutritionally regulated but dispensable for energy balance. Biochim Biophys Acta Mol Cell Biol Lipids. 2026 Apr; 1871(3):159735.
-
O'Brien KA, Toledo-Jaldin L, Gu W, Houck JA, Lazo-Vega L, Miranda-Garrido V, Yung HW, Yasini H, Moore LG, Reisz JA, Simonson TS, Shortt J, Stalker M, D'Alessandro A, Julian CG. Dysregulated Fatty Acid Metabolism in Preeclampsia Among Highland Andeans: Insights Into Adaptive and Maladaptive Placental Metabolic Phenotypes. FASEB J. 2025 Nov 30; 39(22):e71254.
-
Solo KJ, Zhang Y, Bharathi SS, Zhang BB, Richert AC, Schmidt AV, Van't Land C, D'Annibale O, Wood TC, Goetzman ES. Oral octanoylcarnitine alleviates exercise intolerance in mouse models of long-chain fatty acid oxidation disorders. JCI Insight. 2025 Nov 24; 10(22).
-
Myerson M, Warden BA, Saseen JJ, Paparodis R. Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction. J Am Heart Assoc. 2025 Oct 21; 14(20):e044134.
-
Nicholls SJ, Nelson AJ, Ray KK, Ballantyne CM, Ditmarsch M, Kling D, Hsieh A, Szarek M, Kastelein JJ, Davidson MH. Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis. J Am Coll Cardiol. 2025 Oct 07; 86(14):1046-1056.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|